Skip Navigation Links

Bookmark and Share
HCmed Signs a Global Development Agreement with Global Biotechnology Leader CSL Behring

on 5/3/2021
Companies Initiated Phase I trial in December 2020 TAIPEI, May 4, 2021 /PRNewswire/ -- HCmed today announces the start of a strategic partnership with global biotherapeutics leader CSL Behring t...

Full "IntellAsia: Resources" article

Disclaimer | Terms Of Use And Privacy Statement

© Metals News. All rights reserved.